BioSpace News Archive

Elpiscience Biopharmaceuticals, Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation cancer immunotherapies, announced that the Center of Drug Evaluation has cleared Elpiscience’s Investigational New Drug Application for ES002 to initiate a Phase I clinical trial in China.

Global genomics solutions provider Integrated DNA Technologies is empowering researchers to drive scientific discoveries in gene editing with the release of Alt-R HDR Donor Blocks, an improved solution for increasing homology-directed repair rates in large fragment knock-in experiments.

Royal Philips, a global leader in health technology, announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on its handheld point-of-care ultrasound – Lumify.

ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, announced that President and CEO James Barlow will present on the company and its multiple immune-oncology therapeutic development programs targeting immune-excluded cold cancers at the upcoming 2022 BIO CEO & Investor Conference.

Nano healthcare technology has been gaining immense popularity in the last few years.

The global market for ingestible smart pills is growing at a healthy pace in the last few years, thanks to the growing emphasis of the key players on the research and development activities.

In vitro protein expression is a well-developed and efficient technique for synthesizing proteins in cell lysates rather than cultured cells.

Treatment of gynecological cancer includes the different medications, surgeries, therapies, and chemotherapy.

Gastrointestinal stromal tumor is considered as one of the most common mesenchymal tumors across the globe.

The global wireless fetal monitoring systems market is foreseen to see expansion on the back of rising awareness among pregnant women.